Call 800 665 0411 to learn about our services for your stock

Search   Follow Investorideas on Twitter   Investorideas is on Facebook   Investorideas is on Youtube   Investorideas is on Pinterest  Investorideas is on stocktwits   Investorideas is on tumblr   Investorideas is on LinkedIn   Investorideas Instagram   Investorideas Telegram   Investorideas Gettr   Investorideas RSS

Share on StockTwits

AI Health Stock News: GBT (OTCPINK: GTCH) Researching AI based, Robotics Technology for the Medical Field

GBT Technologies Inc.

Investorideas Featured Company: GBT Technologies Inc. (OTC PINK: GOPHD)


SAN DIEGO - January 21, 2021 ( Newswire) GBT Technologies Inc. (OTCPINK: GTCH) ("GBT", or the "Company") is researching AI based, robotics technology for the medial field. Due to the expected growth in the global medical robotics industry through 2023*, a wide range of robots are being developed to serve in a variety of roles within the medical environment. Probably one of the most famous medicals robot is the da Vinci Surgical System**, that was approved by the FDA in 2000. This system is designed to perform minimally invasive surgeries and is controlled by a surgeon from a console.

GBT is commencing new research that is targeting medical application robotics, empowered by its AI system. In this research, the Company will focus on the innovation and technological advancements that is offered by AI to enable medical robots achieving higher standards. Using AI technology, robots can perform minimally invasive procedures with high accuracy and precision. For example, performing laser incisions on soft tissue, especially for microsurgeries. Using expert system guidance, one of the research goals, is to perform robotic based laser incisions simulation based on surgeon high level commands where an AI engine controls a high precision laser beam to achieve a desired incision shape, length, and depth. Another planned topic to be researched is robotic assistance for biopsies where under robotic guidance a surgeon can performs a biopsy based on 3D imaging of the area. The Company plans to develop simulated procedures and flows to be tested for further medical purposes.

"The field of robotics is under constant development in many areas of our daily lives. One of the popular fields that robotics researchers invest major efforts, is the medical arena. Today's robots can take patient's vitals, assist with prosthetics, perform an endoscopy (looking inside the human body typically via Camera) and complex surgeries. As the demand for less invasive, less painful, high precision procedures is rapidly growing, we will be evaluating our AI system for these types of procedure. Our goal is to utilize a high precision mechanical arm based robotic system in simulated medical procedures supervised by an expert system. The plan is to investigate into soft tissues ultra-fine laser incisions, 3D imaging, and intelligent navigation to organs sites of interest. Our goal is to develop low and high level programs to command robotic mechanism for various physicians assisting tasks. Our research will involve full robotic automation, a physician assistant, and a combination of both. The research is planned to be on-going and we plan to produce technical papers with conclusions and results. Based on our results, we will then seek commercial partners in this domain." Said Danny Rittman the Company's CTO.

* Source: Medical Robotics Market To Reach Over US$ 20 Bn By 2023 - Credence Research

** Source: da Vinci Surgical System - Wikipedia

About Us

GBT Technologies, Inc. (OTC PINK: GTCH) ("GBT") ( is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT's mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT's goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT's vision is to produce this system as a low cost, secure, private-mesh-network between any and all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements". Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website ( In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company's ability to raise capital on acceptable terms, if at all, the Company's successful development of its products and the integration into its existing products and the commercial acceptance of the Company's products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.


Dr. Danny Rittman, CTO

GBT Technologies Inc. (OTC Pink: GTCH) is a featured tech stock on

Visit profile page

Get News Alerts on GBT Technologies Inc.

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GTCH is a PR, social media and publishing client and compensates

Contact management and IR of each company directly regarding specific questions.

More disclaimer info: Learn more about publishing your news release and our other news services on the newswire and

Global investors must adhere to regulations of each country. Please read privacy policy: - investing ideas in tech stocks- mobile payments, social media, AI and Robotics, Drone Stocks, GPS, Internet of Things (IoT)

Like Tech Stocks? View our Tech Stocks Directory